Navigation Links
Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
Date:12/8/2008

cal and related costs of obesity are $123 billion per year according to a 2005 report by the International Diabetes Federation. Being obese or overweight is associated with increased risk of a number of conditions, including heart disease, stroke, diabetes, cancer and osteoarthritis. Medical treatment options for obese and overweight people currently are limited.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independently and with partners, including Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the therapeutic indication, tolerability, side effects, efficacy and potential of lorcaserin; future results of clinical trials; future activities and announcements relating to lorcaserin, including the BLOOM results and the submission of an NDA for lorcaserin; and about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ mater
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Arena Pharmaceuticals to Present at the Piper Jaffray 20th Annual Health Care Conference
2. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
3. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
4. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
5. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
6. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
7. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
8. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
9. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
10. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
11. Arena Pharmaceuticals Announces Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 As part of its ... LLP has been closely monitoring the ongoing meeting ... Obstetrics and Gynecology Devices Panel, which has ... cancer risks associated with the use of power ... a report published by Dow Jones Business News, ...
(Date:7/11/2014)... MA (PRWEB) July 11, 2014 ... at least $50 billion in fuel costs ... immediately. The current GHG standards ... have taken it upon themselves to install ... include: , 1.    Idle reduction technologies , 2.    Efficient ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The ... Supplements, Specialty Nutrients, Animal Feed), Applications (Regular, Therapeutic, ... - Global Trends & Forecasts to 2019 ” ... an analysis and forecasting of the market value ... identifies the driving and restraining factors for the ...
(Date:7/11/2014)... 2014 Presently, disposable medical suppliers call ... and supplies segment. During the past two decades, the ... (on an average 12.5% per year), primarily owing to ... the US is the largest market for disposable medical ... 40%. The second position is held by Europe with ...
(Date:7/11/2014)... York, NY (PRWEB) July 11, 2014 ... during the five years to 2014 on the heels ... of 2010 prompted farmers to dedicate a larger share ... ethanol production. More specifically, the regulations required the mixing ... rapidly expanding biofuel production in the United States created ...
Breaking Medicine News(10 mins):Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 2Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 3Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3
... Continuing Education Lecture Series for Healthcare ... ... the,most common and most malignant type of glioma. Healthcare professionals,face many ... mean length of survival in patients is less than,one year., ...
... NORTH ANDOVER, Mass., March 24 Andover,Medical, Inc. (OTC ... medical equipment ("DME"), announced today that the,Company anticipates closing ... Complete terms of the financing can be,found in the ... 19, 2008 and,available at http://www.sec.gov ., On ...
... due to blocked arteries remains the leading cause of disease ... University College of Medicine researcher is helping to open new ... in the department of biomedical sciences, is researching mutant forms ... the human body grow new blood vessels to restore blood ...
... The Food Allergy &,Anaphylaxis Network (FAAN) will hold ... March 29, 2008. Many families struggle,with how best to ... living with food allergies for years or are dealing ... attendees will learn tips and strategies for living better,while ...
... activity among youth , , MONDAY, March 24 (HealthDay ... teen pregnancies without increasing levels of sexual intercourse ... researchers who reviewed data from a 2002 national ... 15 to 19. , There is ongoing debate ...
... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced ... present at the 12th Annual Sidoti Emerging Growth,Institutional ... p.m. (ET) at the,Grand Hyatt Hotel in New ... global healthcare supplier that develops,manufactures and distributes over-the-counter ...
Cached Medicine News:Health News:Adult Glioblastoma: Strategies, Challenges, and Opportunities 2Health News:Andover Medical, Inc. Anticipates Closing $2.0 Million Private Financing 2Health News:Andover Medical, Inc. Anticipates Closing $2.0 Million Private Financing 3Health News:FSU researcher's 'mutant' proteins could lead to new treatment for heart disease 2Health News:FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in Baltimore 2Health News:FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in Baltimore 3Health News:Sex Ed Can Help Prevent Teen Pregnancy 2
(Date:7/11/2014)... CHAPEL HILL, N.C. , July 11, 2014 ... component of pharmaceutical marketing and, consequently, organizations are ... specifically for patients. As part of ... learned it,s important to educate, communicate and engage ... from disease awareness to patient empowerment. By mapping ...
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... the "Global and Chinese Medical X-ray Film Industry ... http://photos.prnewswire.com/prnh/20130307/600769 Global And ... professional and in-depth study on the current state of ... on the Chinese situation. The report provides a ...
(Date:7/11/2014)... July 11, 2014  Kindred Hospital Houston Northwest, ... the opening of its new outpatient wound healing ... to people with chronic, hard to heal wounds. ... lead to amputation, lower leg wounds related to ... closure, and traumatic injury wounds which are complex ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global and Chinese Medical X-ray Film Industry Report 2014 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2
... Feb. 17, 2011 Reportlinker.com announces that ... in its catalogue: Antivirals ... Combination Therapies to be Major Drivers HIV ... http://www.reportlinker.com/p0397049/Antivirals-Market-to-2016---Antiretroviral-Agents-and-Combination-Therapies-to-be-Major-Drivers-HIV-and-Hepatitis-C-Markets.html Antivirals Market ...
... Medical Devices, Inc. announced today that it has selected ... Schein Inc. (Nasdaq: HSIC ), the largest ... dental, medical and veterinary practitioners, as the exclusive distributor ... is the first and only surgical tourniquet single-use device ...
Cached Medicine Technology:Reportlinker Adds Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets 2Reportlinker Adds Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets 3OHK Medical Devices Selects Henry Schein as Exclusive Distributor of HemaClear® 2OHK Medical Devices Selects Henry Schein as Exclusive Distributor of HemaClear® 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: